1. Home
  2. WOOF vs SLBT Comparison

WOOF vs SLBT Comparison

Compare WOOF & SLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Petco Health and Wellness Company Inc.

WOOF

Petco Health and Wellness Company Inc.

N/A

Current Price

$2.45

Market Cap

713.2M

ML Signal

N/A

Logo SL Science Holding Limited Ordinary Shares

SLBT

SL Science Holding Limited Ordinary Shares

N/A

Current Price

$0.52

Market Cap

644.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
WOOF
SLBT
Founded
1965
N/A
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Other Specialty Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
713.2M
644.9M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
WOOF
SLBT
Price
$2.45
$0.52
Analyst Decision
Hold
Analyst Count
12
0
Target Price
★ $3.47
N/A
AVG Volume (30 Days)
★ 3.6M
46.5K
Earning Date
12-08-2026
10-26-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 108.11
N/A
EPS
★ 0.08
N/A
Revenue
★ $5,961,467,000.00
N/A
Revenue This Year
$0.46
N/A
Revenue Next Year
$1.23
N/A
P/E Ratio
$30.88
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.14
$0.57
52 Week High
$3.78
$6.25

Technical Indicators

Market Signals
Indicator
WOOF
SLBT
Relative Strength Index (RSI) 40.01 22.09
Support Level $2.21 N/A
Resistance Level $2.51 $1.75
Average True Range (ATR) 0.17 0.13
MACD -0.06 -0.01
Stochastic Oscillator 2.76 4.94

Price Performance

Historical Comparison
WOOF
SLBT

About WOOF Petco Health and Wellness Company Inc.

Petco Health and Wellness Co Inc is a pet specialty retailer focused on improving the lives of pets, pet parents, and its own partners with pet care centers in approximately 50 states, the District of Columbia and Puerto Rico. The Company also offers an expanded range of consumables, supplies, and services through its website and mobile app.

About SLBT SL Science Holding Limited Ordinary Shares

SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

Share on Social Networks: